ArticleFrontiers in oncology2026
Case Report: A rare case of over 45 years' survival in a patient with tonsillar adenoid cystic carcinoma.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tonsillar adenoid cystic carcinoma (TACC) is an extremely rare malignancy with an unpredictable clinical course. We report an unusual case of TACC with a 47-year disease trajectory, characterized by prolonged indolent behavior followed by late and relatively rapid clinical progression. The patient was initially diagnosed with left tonsillar ACC in 1977 after presenting with dysphagia and underwent tonsillectomy followed by postoperative radiotherapy. A local recurrence involving the left soft palate occurred in 1996-1997 and was treated with surgical resection and tongue flap reconstruction, after which the disease remained clinically stable for many years. In 2018, recurrent ACC of the soft palate was confirmed in the radical resection specimen, and the patient underwent radical resection via a mandibulotomy approach followed by reconstruction and adjuvant concurrent chemoradiotherapy. Molecular profiling of the available 2018 recurrent soft palate lesion revealed NOTCH2 copy number gain and structural variants involving MTOR and SPEN. Regional cervical lymph node metastasis was confirmed in 2022, followed by intracranial disease progression in 2023. The patient died in 2024 from complications of progressive intracranial and systemic metastases. To our knowledge, this represents one of the longest documented clinical courses of TACC with integrated genomic analysis. This case highlights the potential for TACC to remain indolent for decades before transitioning to late regional and systemic progression, underscoring the importance of long-term surveillance and comprehensive clinicopathological and molecular evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.